Task: Answer the multiple-choice question.
Query: Which drug exhibits a 11.082% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) CCCNC(=O)NC(=O)CSc1cccc(C(F)(F)F)c1
(b) Cc1ccc(O)c(C(=O)CC(=O)c2cccc(F)c2)c1
(c) COc1ccc(C(=O)NN/C(=N/S(=O)(=O)c2ccc(C)cc2)c2ccccc2)cc1
Answer: a. CCCNC(=O)NC(=O)CSc1cccc(C(F)(F)F)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)NC(=O)CSc1cccc(C(F)(F)F)c1
CCCNC(=O)NC(=O)CSc1cccc(C(F)(F)F)c1
N-(propylcarbamoyl)-2-[3-(trifluoromethyl)phenyl]sulfanylacetamide